Statin Use Is Associated with Incident Diabetes Mellitus among Patients in the HIV Outpatient Study

Journal of Acquired Immune Deficiency Syndromes

Volumn 69, Issue 3, 2015, Pages 306-311

  Lichtenstein, Kenneth A ^a   Hart, Rachel L D ^b   Wood, Kathleen C ^b   Bozzette, Samuel ^b,c   Buchacz, Kate ^d   Brooks, John T ^d   Durham, Marcus D ^d   Hays, Harlen ^b   Hankerson, Darlene ^b   Subramanian, Thilakavathy ^b   Armon, Carl ^b   Dean, Bonnie ^b   Franklin, Dana ^b   Palella, Frank J ^e   Chmiel, Joan S ^e   Jahangir, Saira ^e   Flaherty, Conor Daniel ^e   Dixon Evans, Jerian Denise ^e   Stewart, Cheryl ^a   Hammer, John ^f   Greenberg, Kenneth S ^f   Widick, Barbara ^f,l   Franklin, Rosa ^f   Yangco, Bienvenido G ^g   Chagaris, Kalliope ^g   Ward, Doug ^h   Thomas, Troy ^h   Starr, Matt ^h   Fuhrer, Jack ⁱ   Ording Bauer, Linda ⁱ   Kelly, Rita ⁱ   Esteves, Jane ⁱ   Tedaldi, Ellen M ^j   Christian, Ramona A ^j   Ruley, Faye ^j   Beadle, Dania ^j   Graham, Princess ^j   Novak, Richard M ^k   Wendrow, Andrea ^k   Smith, Renata ^k   Young, Benjamin ^l   Scott, Mia ^l   more..

^a DEPARTMENT OF MEDICINE   (United States)

^b CERNER CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f ROSE MEDICAL CENTER   (United States)

^g INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^h Dupont Circle Physicians Group   (United States)

ⁱ STONY BROOK UNIVERSITY   (United States)

^j TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^l Apex Family Medicine and Research   (United States)

more..

Author keywords

diabetes; low density lipoprotein; statin

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN;

ADULT; AGE; ARTICLE; BLACK PERSON; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS C; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; CARDIOVASCULAR DISEASES; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HIV INFECTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84933046694     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000581     Document Type: Article

References (35)

1. Collins R, Armitage J, Parish S, et al. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
2. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol. 2004;110:227-239.
3. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149-1158.
4. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623-1630.
5. Carter AA, Gomes T, Camacho X, et al. Risk of incident diabetes among patients treated with statins: population based study. BMJ. May 23, 2013; 346:f2610. doi: 10.1136/bmj.f2610.
6. Coleman CI, Reinhart K, Kluger J, et al. The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. Curr Med Res Opin. 2008;24:1359-1362.
7. Mills EJ, Wu P, Chong G, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170255 patients from 76 randomized trials. QJM. 2011;104:109-124.
8. Shah RV, Goldfine AB. Statins and risk of new-onset diabetes mellitus. Circulation. 2012;126:E282-E284.
9. Ridker PM, Pradhan A, MacFadyen JG, et al. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380:565-571.
10. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375:735-742.
11. Culver AL, Ockene IS, Balasubramanian R, et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med. 2012;172:144-152.
12. Goldstein MR, Mascitelli L. Do statins cause diabetes? Curr Diab Rep. 2013;13:381-390.
13. Triant VA, Lee H, Hadigan C, et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007; 92:2506-2512.
14. Brooks JT, Buchacz K, Gebo KA, et al. The public health perspective. Am J Public Health. 2012;102:1516-1526.
15. Freiberg MS, Chang CCH, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614-622.
16. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45:1593-1601.
17. Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23:1059-1067.
18. Spradling PR, Richardson JT, Buchacz K, et al. Trends in hepatitis C virus infection among patients win the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr. 2010;53:388-396.
19. Rubin DB. Multiple Imputation for Nonresponse in Surveys. 1987; John Wiley & Sons, Inc. Available at: http://onlinelibrary.wiley.com/doi/10.1002/ 9780470316696.fmatter/pdf. Accessed March 15, 2015.
20. Ahdieh L, Gange SJ, Greenblatt R, et al. Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. Am J Epidemiol. 2000;152:923-933.
21. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
22. Centers for Disease Control and Prevention. National Diabetes Statistical Report, 2014. Estimates of Diabetes and Its Burden in the United States. Available at: http://www.cdc.gov/diabetes/pubs/statsreport14/nationaldiabetes-report-web.pdf
23. Dube MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37:613-627.
24. Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-1735.
25. Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet. 2002;360: 1747-1748.
26. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:651-681.
27. th Conference on Retroviruses and Opportunistic Infection, Boston, MA, February 27, 2011.
28. Tien PC, Schneider MF, Cox C, et al. Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes. J Acq Imm Def. 2012;61:334-340.
29. Brown TT, Cole SR, Li XH, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study. Arch Intern Med. 2005;165:1179-1184.
30. Butt AA, McGinnis K, Rodriguez-Barradas MC, et al. HIV infection and the risk of diabetes mellitus. AIDS. 2009;23:1227-1234.
31. Antonelli A, Ferrari SM, Giuggioli D, et al. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. WJD. 2014;5:586-600.
32. Negro F. Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases. J Hepatol. 2014;61:S69-S78.
33. Buchacz K, Baker RK, Palella FJ, et al. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther. 2013;18:65-75.
34. Sukhija R, Prayaga S, Marashdeh M, et al. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med. 2009;57:495-499.
35. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart association Task Force on Practice guidelines. J Am Coll Cardiol. 2014;24(25 suppl 2):129:S1-S45.